More about

Hidradenitis Suppurativa

News
April 18, 2025
5 min read
Save

Q&A: Medical marijuana can alleviate pain, anxiety associated with skin disease

Patients are growing increasingly interested in medical marijuana. As this interest grows, dermatologists must be prepared to navigate the ethical, legal and scientific complexities of its use, according to an expert.

News
April 11, 2025
2 min read
Save

Study finds shared genetic susceptibility of psoriasis, hidradenitis suppurativa

Researchers reported a shared genetic susceptibility of psoriasis and hidradenitis suppurativa, highlighting a need for patients with both conditions to receive unique disease management.

News
March 17, 2025
2 min read
Save

New data support efficacy, safety of povorcitinib for hidradenitis suppurativa

Newly released data from the phase 3 STOP-HS clinical trial program reveal positive results in hidradenitis suppurativa from povorcitinib treatment, Incyte announced in a press release.

News
March 04, 2025
5 min read
Save

GLP-1 receptor agonists associated with acne vulgaris in women

Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications, have been found to be associated with new onset acne in women, according to a research letter published in Journal of the American Academy of Dermatology.

News
February 20, 2025
6 min read
Save

Connection between skin disease, heart health ushers in ‘holistic’ era of dermatology

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.

News
February 18, 2025
1 min read
Save

Bimzelx sustains hidradenitis suppurativa control up to 2 years

New data showed that Bimzelx sustained disease control of hidradenitis suppurativa up to 2 years, UCB announced in a press release.

News
February 09, 2025
3 min watch
Save

VIDEO: JAK inhibitors in dermatology effective, ‘safer than we could have ever hoped for’

MIAMI BEACH, Fla. — Janus kinase inhibitors are an incredibly important, new tool that have exemplified both high efficacy and safety, according to a speaker at South Beach Symposium.

News
January 27, 2025
1 min read
Save

Diversity in melasma trials sets precedent for inclusive research in other indications

Fair representation of patients with skin of color in melasma trials has signaled a trend toward inclusivity in dermatology, setting a precedent for other indications, according to a study.

News
January 16, 2025
1 min read
Save

Bimzelx 320 mg, 2 mL single-injection option now available for multiple indications

The single-injection 2 mL prefilled syringe and autoinjector for Bimzelx 320 mg is now available, UCB announced in a press release.

News
December 26, 2024
4 min read
Save

Biosimilar boom set to expand treatment landscape for IBD, inflammatory diseases in 2025

The expansion of safe and effective FDA-approved biosimilars for inflammatory bowel disease set to launch in early 2025 may improve access to care, with the potential to reduce health care costs and revolutionize the treatment landscape.

View more